Lordick, Florian

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet

Gastric Cancer Management and OutcomesHER2/EGFR in Cancer Research

Cited by 7,302

Randomized Phase III Study of Panitumumab with Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared with FOLFIRI Alone as Second-Line Treatment in Patients with Metastatic Colorectal Cancer

Peeters, M., Price, T. J., Cervantes, A., Sobrero, A. F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C. J. A., et al. (2010) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 1,005

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Rha, S. Y., Oh, D.-Y., Yañez, P., Bai, Y., Ryu, M.-H., Lee, J., Rivera, F., Alves, G. V., Garrido, M., Shiu, K.-K., et al. (2023) · The Lancet Oncology

Gastric Cancer Management and OutcomesCancer Immunotherapy and Biomarkers

Cited by 690

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Shah, M. A., Shitara, K., Ajani, J. A., Bang, Y.-J., Enzinger, P., Ilson, D., Lordick, F., Van Cutsem, E., Gallego Plazas, J., Huang, J., et al. (2023) · Nature Medicine

Gastric Cancer Management and OutcomesEsophageal Cancer Research and Treatment

Cited by 681

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

Götze, H., Friedrich, M., Taubenheim, S., Dietz, A., Lordick, F., & Mehnert, A. (2020) · Supportive Care in Cancer

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 281

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis

Oba, K., Paoletti, X., Alberts, S., Bang, Y.-J., Benedetti, J., Bleiberg, H., Catalano, P., Lordick, F., Michiels, S., Morita, S., et al. (2013) · JNCI Journal of the National Cancer Institute

Gastric Cancer Management and OutcomesStatistical Methods in Clinical Trials

Cited by 168

Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer

Marschner, N., Zacharias, S., Lordick, F., Hegewisch-Becker, S., Martens, U., Welt, A., Hagen, V., Gleiber, W., Bohnet, S., Kruggel, L., et al. (2020) · JAMA Network Open

Cancer survivorship and careHealth Systems, Economic Evaluations, Quality of Life

Cited by 90

The association between an anxiety disorder and cancer in medical history

Zeynalova, N., Schimpf, S., Setter, C., Yahiaoui-Doktor, M., Zeynalova, S., Lordick, F., Loeffler, M., & Hinz, A. (2019) · Journal of Affective Disorders

Cancer survivorship and careAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 22